AllQuantitative Report
Argus•April 14, 2021
Argus•April 14, 2021VCEL: Rating decreased to a HOLD
Summary
Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company dedicated to the identification, development, and commercialization of innovative therapies that enable the body to repair and regener
Subscribe to Yahoo Finance Plus Essential for full access
Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level
Actions
Download Full ReportRelated Reports
- Analyst Report: Johnson & JohnsonApr 18, 2024 •
JNJ
- Market Update: DFS, JNJ, LVS, TRVApr 18, 2024 •
DFS, JNJ, LVS, TRV
- XNCR: Lowering target price to $20.00Apr 17, 2024 •
XNCR
- RGNX: Lowering target price to $18.00Apr 17, 2024 •
RGNX
- BLFS: Lowering target price to $17.00Apr 17, 2024 •
BLFS